LEADER 03843nam 2200673 a 450 001 9911019645603321 005 20251116153959.0 010 $a9786613679376 010 $a9781280768606 010 $a1280768606 010 $a9780470719381 010 $a0470719389 010 $a9780470716922 010 $a0470716924 035 $a(CKB)1000000000687637 035 $a(EBL)703784 035 $a(SSID)ssj0000715155 035 $a(PQKBManifestationID)11956079 035 $a(PQKBTitleCode)TC0000715155 035 $a(PQKBWorkID)10700898 035 $a(PQKB)10084974 035 $a(MiAaPQ)EBC703784 035 $a(OCoLC)264621072 035 $a(Perlego)2755313 035 $a(iGPub)WILEYB0013035 035 $a(EXLCZ)991000000000687637 100 $a20120309d1965 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCiba Foundation Symposium $ecomplement /$fedited by G.E.W. Wolstenholme and Julie Knight 205 $a1st ed. 210 $aLondon $cJ. & A. Churchill$d1965 215 $a1 online resource (418 p.) 225 1 $aCiba Foundation symposium 300 $aDescription based upon print version of record. 311 08$a9780470722824 311 08$a0470722827 320 $aIncludes bibliographical references and indexes. 327 $aCOMPLEMENT; Preface; Editors' note; Contents; Chairman's introduction; Mechanism of haemolysis by complement; Discussion; Nomenclature and fixation of C'3 components; Identity of complement components from different species; Enzymic nature of C'2; Binding of C'2 to EAC'1,4 cells; Definition of complement; Small molecular weight inhibitors of complement action; Discussion; Mechanisms of activation of C'1 and inhibition of C'1 esterase; Discussion; Problems in determining the sites of synthesis of complement components; Discussion; Mechanism of the damage-producing steps of immune haemolysis 327 $aDiscussionEffects of complement on sensitized nucleated cells; Discussion; Immune bactericidal and bacteriolytic reactions; Discussion; Electron microscope studies of immune cell lysis; Discussion; Complement and the activity of phagocytes; Discussion; lmmune adherence; Discussion; Complement, conglutinin and immuno-conglutinins; Discussion; Differentiation in vitro of antigen-induced histamine release from complement-dependent immune injury; Discussion; The possible ro?le of complement in autoaggressive processes; Discussion; The ro?le of complement in haemolytic processes in vivo; Discussion 327 $aComplement and the paroxysmal nocturnal haemoglobinuria red cellDiscussion; General Discussion; Standard preparations of complement components; Characteristics of human red cells; Complement in disease processes; Effects of complement deficiency; Ro?le of complement in delayed hypersensitivity reactions; Chairrnan's closing remarks; Author index; Subject index 330 8 $aThe Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world. 410 0$aCiba Foundation symposium. 606 $aComplement (Immunology)$vCongresses 615 0$aComplement (Immunology) 676 $a616.07/9 701 $aWolstenholme$b G. E. W$g(Gordon Ethelbert Ward)$063039 701 $aKnight$b Julie$0512647 712 02$aCiba Foundation. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911019645603321 996 $aCiba Foundation Symposium$93004923 997 $aUNINA